A randomized study of etoposide and carboplatin with or without paclitaxel in the treatment of small cell lung cancer

被引：0
|
作者：
Birch, R
Weaver, CH
Hainsworth, JD
Bobo, C
Greco, FA
机构：
[1] RESPONSE ONCOL INC, 1775 MORIAH WOODS BLVD, MEMPHIS, TN 38117 USA
[2] SARAH CANNON CANC CTR, NASHVILLE, TN USA
来源：
SEMINARS IN ONCOLOGY | 1997年 / 24卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：135 / 137
页数：3
相关论文
共 50 条
  • [21] Carboplatin plus etoposide or topotecan for small-cell lung cancer
    Arrieta, Oscar
    Lara-Mejia, Luis
    Zatarain-Barron, Zyanya Lucia
    LANCET ONCOLOGY, 2020, 21 (09): : 1132 - 1134
  • [22] CISPLATIN/ETOPOSIDE VERSUS CARBOPLATIN/ETOPOSIDE CHEMOTHERAPY AND IRRADIATION IN SMALL-CELL LUNG-CANCER - A RANDOMIZED PHASE-III STUDY
    KOSMIDIS, PA
    SAMANTAS, E
    FOUNTZILAS, G
    PAVLIDIS, N
    APOSTOLOPOULOU, F
    SKARLOS, D
    SEMINARS IN ONCOLOGY, 1994, 21 (03) : 23 - 30
  • [23] CARBOPLATIN AND ETOPOSIDE IN EXTENSIVE SMALL-CELL LUNG-CANCER
    VIREN, M
    LIIPPO, K
    OJALA, A
    HELLE, L
    HINKKA, S
    HUOVINEN, R
    JAKOBSSON, M
    JARVINEN, M
    PALOHEIMO, S
    SALMI, R
    SALOMAA, ER
    NIKKANEN, V
    ACTA ONCOLOGICA, 1994, 33 (08) : 921 - 924
  • [24] CARBOPLATIN AND ETOPOSIDE AS OUTPATIENT TREATMENT OF ADVANCED NON-SMALL-CELL LUNG-CANCER
    PRONZATO, P
    LANDUCCI, M
    VAIRA, F
    VIGANI, A
    BERTELLI, G
    CHEMOTHERAPY, 1994, 40 (02) : 144 - 148
  • [25] A Phase 2 Randomized Trial of Paclitaxel and Carboplatin with or without Panitumumab for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer
    Crawford, Jeffrey
    Swanson, Paul
    Schwarzenberger, Paul
    Sandler, Alan
    Prager, Diane
    Zhang, Kathy
    Freeman, Daniel J.
    Johnson, Carol W.
    Krishnan, Kartik
    Johnson, David
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (12) : 1510 - 1518
  • [26] Paclitaxel-etoposide-carboplatin/cisplatin versus etoposide-carboplatin/cisplatin as first-line treatment for combined small-cell lung cancer: a retrospective analysis of 62 cases
    Li, Yue-Ya
    Zhou, Chan
    Yang, Deng-Xia
    Wang, Jing
    Liu, Zhu-Jun
    Wang, Xin-Yue
    Li, Kai
    CANCER BIOLOGY & MEDICINE, 2015, 12 (02) : 117 - 125
  • [27] Phase III study of cyclophosphamide, doxorubicin, and etoposide compared with carboplatin and paclitaxel in patients with extensive disease small-cell lung cancer
    De Jong, Wouter K.
    Groen, Harry J. M.
    Koolen, Mia G. J.
    Biesma, Bonne
    Willems, Luuk N. A.
    Kwa, Hian-Bie
    van Bochove, Aart
    van Tinteren, Harm
    Smit, Egbert F.
    EUROPEAN JOURNAL OF CANCER, 2007, 43 (16) : 2345 - 2350
  • [28] Paclitaxel/carboplatin/etoposide versus paclitaxel/topotecan for extensive stage small cell lung cancer: A Minnie Pearl Cancer Research Network randomized prospective phase II trial.
    Thompson, DS
    Hainsworth, JD
    Morrissey, LH
    Erland, JB
    Burris, HA
    Joseph, G
    Corso, SW
    Spremulli, E
    Greco, FA
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 667S - 667S
  • [29] Paclitaxel/carboplatin/etoposide versus paclitaxel/topotecan for extensive-stage small cell lung cancer: A minnie pearl cancer research network randomized, prospective phase II trial
    Greco, FA
    Thompson, DS
    Morrissey, LH
    Erland, JB
    Burris, HA
    Spigel, DR
    Joseph, G
    Corso, SW
    Spremulli, E
    Hainsworth, JD
    ONCOLOGIST, 2005, 10 (09): : 728 - 733
  • [30] Paclitaxel and carboplatin in the treatment of small-cell lung cancer patients resistant to cyclophosphamide, doxorubicin, and etoposide: A non-cross-resistant schedule
    Groen, HJM
    Fokkema, E
    Biesma, B
    Kwa, B
    van Putten, JWG
    Postmus, PE
    Smit, EF
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (03) : 927 - 932
12345